You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Medical Marijuana Articles
Popular Medical Marijuana Articles
Highly Recommended Medical Marijuana Articles
Send a link to this page to your friends and colleagues.
The company, GW Pharma, is in the process of creating a collection of cannabinoid-based drugs, including one that takes aim at diabetes. The first of this type of drug the company has produced is Sativex, a nasal spray used to treat spasms associated with multiple sclerosis. Sativex has been okayed in eight countries, and is currently awaiting FDA approval in the United States.
The diabetes drug, GWP4204, is currently in its second phase of testing after a small but successful double-blind study. That study featured 62 type 2 patients who received various levels of the oral-administered drug or a placebo.
Those who took the drug experienced a variety of positive effects on diabetic-related symptoms, including:
• Reduced fasting glucose levels;
• Improved pancreatic beta cell function;
• Increased adiponectin, a protein that regulates glucose levels and the breakdown of fatty acids;
• Reduced systolic blood pressure;
• Reduced inflammation levels;
• Increased insulin sensitivity; and
• Increased levels of the hormone GLP-1, which plays a critical role in the secretion of insulin.
"We are very pleased that the promising results seen for GWP42004 in our pre-clinical research have been borne out in this first early proof of principle clinical trial," said Dr. Stephen Writer, GW's director of research and development.
"If larger studies confirm these findings, GWP42004 would have the potential to offer a novel orally-administered treatment option within one of the largest therapeutic areas where there still exist serious unmet medical needs," added Dr. Garry Tan, a physician at the Oxford Centre for Diabetes, Endocrinology & Metabolism, and principal investigator of the study.
2 comments - Jul 20, 2013
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.